Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-30

FDA Approved: FULVESTRANT — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved the original application for Fulvestrant (generic) from Eugia US LLC. Fulvestrant is used to treat hormone receptor-positive metastatic breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fulvestrant (fulvestrant)

Snippet

ORIG AP for FULVESTRANT (FULVESTRANT)